Mechanisms of Paradoxical Activation of AMPK by the Kinase Inhibitors SU6656 and Sorafenib.
about
AMP-activated protein kinase - not just an energy sensor.Differential activation of Fyn kinase distinguishes saturated and unsaturated fats in mouse macrophages.AMP-activated protein kinase selectively inhibited by the type II inhibitor SBI-0206965.Inhibitor-induced HER2-HER3 heterodimerisation promotes proliferation through a novel dimer interface.Sorafenib paradoxically activates the RAS/RAF/ERK pathway in polyclonal human NK cells during expansion and thereby enhances effector functions in a dose- and time-dependent manner.
P2860
Mechanisms of Paradoxical Activation of AMPK by the Kinase Inhibitors SU6656 and Sorafenib.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Mechanisms of Paradoxical Acti ...... hibitors SU6656 and Sorafenib.
@en
type
label
Mechanisms of Paradoxical Acti ...... hibitors SU6656 and Sorafenib.
@en
prefLabel
Mechanisms of Paradoxical Acti ...... hibitors SU6656 and Sorafenib.
@en
P2093
P2860
P1476
Mechanisms of Paradoxical Acti ...... hibitors SU6656 and Sorafenib.
@en
P2093
Abdelmadjid Atrih
D Grahame Hardie
Douglas J Lamont
F Romana Auciello
Fiona A Ross
Graeme J Gowans
Simon A Hawley
P2860
P304
813-824.e4
P356
10.1016/J.CHEMBIOL.2017.05.021
P577
2017-06-07T00:00:00Z